![Sarah Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sarah Glass is currently the Chief Operating Officer at n-Lorem Foundation.
She started this position in 2022.
Prior to her current role, she worked at PAREXEL International Corp.
as the Global Head-Rare Diseases.
| Companies | Position | Start |
|---|---|---|
n-Lorem Foundation
 n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Chief Operating Officer | 29/09/2022 |
| Companies | Position | End |
|---|---|---|
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
PAREXEL International Corp.
 PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
n-Lorem Foundation
n-Lorem Foundation Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization for nano-rare patients | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
Choose MarketScreener 
